METIS positive randomized trial! Met Primary Endpoint Tumor Treatment fields significantly delay time to intracranial progression novocure.com/metis-phase-3-…

Daniel Kahneman, Nobel-Winning Pioneer of Behavioral Economics, Dies at 90 wsj.com/finance/invest…

The One Thing You Need to Know: 21 Key Scientific Concepts of the 21st Century by Marcus Chown goodreads.com/book/show/6085…

Elon Musk by Walter Isaacson #au goodreads.com/book/show/1227…

FDA approves a second Alzheimer's drug that can modestly slow disease | AP News apnews.com/article/alzhei…

The Psychology of Money by Morgan Housel goodreads.com/book/show/4188…

Inhibition of IL-11 signalling extends mammalian healthspan and lifespan | Nature nature.com/articles/s4158…

To advance any field you must be open to the perspectives/knowledge of others - especially if this is contrary to prevailing dogma. Brain Fables buff.ly/3V7ozLK

Fastigial Nucleus: the most important structure you’ve never heard of. 6 points on anatomy and function.

1/ This is the next chapter of a story about courageous patients and their families, of multidisciplinary teamwork, and hard-fought steps forward to effective therapy for #DIPG #DMG, a universally lethal cancer of the brain and spinal cord. 🧵nature.com/articles/s4158…

Honored to speak w/ Maria Shriver on the TODAY to discuss how AI is revolutionizing early detection of Alzheimer's. Watch the full conversation here: youtube.com/watch?v=9Mczus… Neurology Artificial Intelligence Program Mayo Clinic Neuro #AI #BrainHealth

Delighted to share AleDinoto et al study on the rare cerebellar attacks in #NMOSD attacks: ➡️ Often coexist with brainstem attacks ➡️ MRIs with peduncle or dentate nucleus lesions ➡️ Should be incorporated in upcoming 2025 #NMOSD diagnostic criteria 👇 neurology.org/doi/10.1212/NX…

Dementia is at the crossroads of prediction and prevention of neurologic disease. Whether we define AD clinically or biologically, robust predictive biomarkers will be central to the care of these patients My editor’s preface from our latest Continuum issue on Dementia ⬇️

Instead of listing my publications, as the year draws to an end, I want to put pressure on the commonplace assumption that productivity must always increase. Good research is disruptive and thinking time is central to high quality scholarship and necessary for disruptive research

In celebration of the legendary career of Professor Peter J. Dyck, who officially retired last month, I kick off today this series with a hidden gem: The 10 P's in the characterization and differential diagnosis of peripheral neuropathy. #NeuropathyClassics #DyckPapers 1/

Our new CASPR2 paper is out ANA Journals 🤩 Headlines: Patients have neuropathic pain & fatigue as their main long term complaints which determine QoL. 😰 These are NOT immunotherapy responsive. 👩🏾‍⚕️💊 We also report other nuggets in this thread 🧵 ⬇️ onlinelibrary.wiley.com/doi/10.1002/an…

When I have a new fellow or resident in our peripheral nerve clinic, I always teach them the importance of defining the neuropathy clinical syndrome. NCS/EMG are valuable, but the neurological exam is the most important (as it should be in neurology but many have forgotten).

This is a great description of what is was like for ⁦Bobby Mukkamala⁩, incoming AMA President and ENT surgeon, to have an awake craniotomy. ⁦Mayo Clinic Neuro⁩ ⁦Mayo Clinic⁩ podcasts.apple.com/us/podcast/cha…

Longevity science has hit the mainstream—but no one agrees on the science wsj.com/health/wellnes…

Coming soon, our first ever issue dedicated to…